Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer to make $10.5 bln push to settle roundup cases, Bloomberg reports
10:49am, Tuesday, 17'th Feb 2026
Bayer is planning to announce a $10.5 billion settlement push to settle current and future cancer lawsuits over its Roundup weedkiller, Bloomberg reported on Tuesday, citing people familiar with the p
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Given Average Rating of “Buy” by Brokerages
03:19am, Monday, 16'th Feb 2026
Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven research firms that are covering the firm, MarketBeat Ratings
Kahn Brothers Reduces Stake in Pfizer Inc by 21.66%
12:00pm, Thursday, 12'th Feb 2026
Insights from Kahn Brothers (Trades, Portfolio)' Fourth Quarter 2025 13F Filing Kahn Brothers (Trades, Portfolio) recently submitted their 13F filing for the f
Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month
08:01am, Thursday, 12'th Feb 2026
WHIPPANY, N.J.--(BUSINESS WIRE)--This American Heart Month, Bayer® Aspirin continues its mission to help people uncover the heart health risk factors they may not see with the launch of the Heart to
Why Bayer Aktiengesellschaft (BAYRY) is a Top Value Stock for the Long-Term
10:40am, Wednesday, 11'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You Looking for a Top Momentum Pick? Why Bayer Aktiengesellschaft (BAYRY) is a Great Choice
01:01pm, Tuesday, 10'th Feb 2026
Does Bayer Aktiengesellschaft (BAYRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
10:52am, Monday, 09'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Oakmark International Strategy Q4 2025 Contributors And Detractors
09:13am, Sunday, 08'th Feb 2026
Oakmark International Strategy Q4 2025 Contributors And Detractors
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?
04:38am, Saturday, 07'th Feb 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $9.25 and traded a
Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention Transcript
Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study
11:50am, Friday, 06'th Feb 2026
Bayer presents positive data on asundexian, which shows superior efficacy with no added bleeding risk, boosting hopes for regulatory approval.
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
10:40am, Friday, 06'th Feb 2026
Here is how Bayer Aktiengesellschaft (BAYRY) and Align Technology (ALGN) have performed compared to their sector so far this year.
Bayer says its experimental blood thinner cuts risk of stroke recurrence by 26%
12:21pm, Thursday, 05'th Feb 2026
Bayer said on Thursday its experimental blood thinner cut the risk of stroke recurrence by 26% in a late-stage trial, in a fresh boost for CEO Bill Anderson's turnaround efforts.
NEW ORLEANS--(BUSINESS WIRE)--Bayer today presented the results from the global, pivotal Phase III OCEANIC-STROKE study evaluating the use of its investigational, once-daily, oral, Factor XIa inhibito
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Decline in Short Interest
01:08am, Sunday, 01'st Feb 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 55,812
